Med. praxi. 2019;16(2):79-84 | DOI: 10.36290/med.2019.013

Antimicrobial therapy of urinary tract infections in primary care

MUDr. Marcela Čechová1, MUDr. Michaela Matoušková2
1 Urologická klinika 2. LF UK a FN Motol, Praha
2 Urocentrum, Praha

Urinary tract infections (UTI) are the second most frequent indication for antimicrobial therapy in primary care. Increasing bacterial
resistance represents a serious epidemiological and therapeutical problem therefore rational approach to antimicrobial therapy
is of great importance. For empirical management of community-acquired cystitis, the most frequent form of UTI, antimicrobials
with low risk of resistance development are preferred with nitrofurantoin considered as the first drug of choice. This article summarizes
current options for treatment of community-acquired UTI.

Keywords: urinary tract infections, antimicrobial therapy, community-acquired lower urinary tract infections, asymptomaticbacteriuria

Published: April 15, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čechová M, Matoušková M. Antimicrobial therapy of urinary tract infections in primary care. Med. praxi. 2019;16(2):79-84. doi: 10.36290/med.2019.013.
Download citation

References

  1. Státní zdravotní ústav - EARS-Net databáze. Dostupné z: https://apps.szu.cz/earsnet/index.php
  2. Státní zdravotní ústav - Močová studie ATB rezistence. Dostupné z: http://www.szu.cz/mocova-studie-atb-rezistence, http://www.szu.cz/uploads/documents/CeM/NRLs/atb/PSMR/mocova_studie/2016/Mocova_studie_ATB_rezistence_2016.pdf
  3. Štefan M. Léčba infekcí močových cest v éře antibiotické rezistence. Urol. praxi 2017; 18(1): 17-20. Go to original source...
  4. Nicolle LE, Bradley S, Colgan R. et al. Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clinical Infectious Diseases 2005; 40: 643. Go to original source...
  5. Kazemier BM, Koningstein FN, Schneeberger C, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015; 15(11): 1324-1333. Go to original source... Go to PubMed...
  6. Bonkat G, Pickard R, Bartoletti R, et al. EAU Guidelines on Urological Infections. EAU Guidelines. Edn. presented at the EAU Annual Congress Copenhagen 2018. Publisher: EAU Guidelines Office. Place published: Arnhem, The Netherlands. Dostupné z: https://uroweb.org/guideline/urological-infections/
  7. Kladenský J, Pacík D, Čermák A. Nifuratel TBL v léčbě akutní nekomplikované uroinfekce. Ces Urol 1998; 2(5): 8-10.
  8. Kladenský J, Toršová V, Chmelařová E. Přínos Nifuratelu pro léčbu akutních nekomplikovaných uroinfekcí. Urolog. pro Praxi 2006; 3: 108-110.
  9. Stanovisko Subkomise pro antibiotickou politiku ČLS JEP (SKAP) k nitrofurantoinu a nifuratelu ze dne 21. 6. 2012, doručené Ústavu po nabytí právní moci rozhodnutí v revizi sp. zn. SUKLS217879/2009. Dostupné z: www.sukl.cz/modules/procedures/doc.php?id=139985905
  10. Karen I, Kolek V, Matoušková M, et al. Doporučení diagnostické a terapeutické postupy pro všeobecné praktické lékaře - Antibiotická terapie respiračních, močových a kožních infekcí v ordinaci všeobecného praktického lékaře. Novelizace 2018. Dostupné z: https://www.svl.cz/files/files/Doporucene-postupy/2017/DP-Antibioticka-terapie-2018.pdf
  11. Bookstaver PB, Bland CM, Griffin B, et al. A Review of Antibiotic Use in Pregnancy. Pharmacotherapy 2015; 35(11): 1052-1062. Go to original source... Go to PubMed...
  12. Kladenský J. Uroinfekce v graviditě - kdy léčit, jak léčit a čím léčit. Urol. praxi 2011; 12(6): 357-360.
  13. Matoušková M, Hanuš M. Záněty dolních močových cest, uroinfekce v graviditě a při laktaci. Urolog. pro praxi 2008; 9(4): 177-183.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.